- Home
- AKRO vs CWEN Comparison
AKRO vs CWEN Comparison
Compare AKRO & CWEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- CWEN
- Stock Information
- Founded
- AKRO 2017
- CWEN 2012
- Country
- AKRO United States
- CWEN United States
- Employees
- AKRO N/A
- CWEN 60
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- CWEN Electric Utilities: Central
- Sector
- AKRO Health Care
- CWEN Utilities
- Exchange
- AKRO Nasdaq
- CWEN Nasdaq
- Market Cap
- AKRO 3.7B
- CWEN 3.8B
- IPO Year
- AKRO 2019
- CWEN 2013
- Fundamental
- Price
- AKRO $54.07
- CWEN $32.29
- Analyst Decision
- AKRO Buy
- CWEN Buy
- Analyst Count
- AKRO 10
- CWEN 6
- Target Price
- AKRO $73.56
- CWEN $36.33
- AVG Volume (30 Days)
- AKRO 4.1M
- CWEN 1.0M
- Earning Date
- AKRO 11-07-2025
- CWEN 11-04-2025
- Dividend Yield
- AKRO N/A
- CWEN 5.36%
- EPS Growth
- AKRO N/A
- CWEN N/A
- EPS
- AKRO N/A
- CWEN 0.64
- Revenue
- AKRO N/A
- CWEN $1,432,000,000.00
- Revenue This Year
- AKRO N/A
- CWEN $4.74
- Revenue Next Year
- AKRO N/A
- CWEN $12.19
- P/E Ratio
- AKRO N/A
- CWEN $50.64
- Revenue Growth
- AKRO N/A
- CWEN 14.65
- 52 Week Low
- AKRO $21.34
- CWEN $24.40
- 52 Week High
- AKRO $58.40
- CWEN $33.22
- Technical
- Relative Strength Index (RSI)
- AKRO 68.64
- CWEN 60.25
- Support Level
- AKRO $53.40
- CWEN $31.40
- Resistance Level
- AKRO $54.31
- CWEN $32.51
- Average True Range (ATR)
- AKRO 0.24
- CWEN 0.77
- MACD
- AKRO -0.18
- CWEN 0.01
- Stochastic Oscillator
- AKRO 74.03
- CWEN 78.36
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About CWEN Clearway Energy Inc. Class C
Clearway Energy Inc is a publicly-traded energy infrastructure investor with a focus on investments in clean energy and owner of modern, sustainable and long-term contracted assets across North America. The company segments its operations into Flexible Generation, renewables and Corporate divisions.